Catalyxx secured €20 million in EU funding to build Europe’s first commercial bio-based alcohols plant, advancing sustainable chemical production.
Catalyxx has received a €20 million grant from the European Union under the RenewChem initiative, a flagship project selected by the Circular Bio-based Europe Joint Undertaking (CBE JU). The funding will enable the company to construct its first commercial-scale bio-based chemicals facility in Europe, representing a significant step in scaling its proprietary technology from pilot operations to industrial production.
As the lead partner of the RenewChem consortium, Catalyxx is collaborating with leading chemical manufacturers Arkema and Evonik Industries, alongside several European technology and innovation partners. Together, the consortium aims to establish Europe’s first industrial-scale production of bio-based alcohols derived from renewable ethanol. These bio-based alcohols are designed as "drop-in" chemicals, meaning they are chemically identical to conventional fossil-based products and can be seamlessly integrated into existing manufacturing processes, infrastructure, and supply chains without requiring modifications.
The project reflects Europe's growing commitment to developing sustainable chemical value chains while reducing dependence on fossil-based feedstocks. The participation of major industry players such as Arkema and Evonik underscores the commercial potential and increasing market demand for renewable, high-performance chemical intermediates.
Commenting on the announcement, Joaquín Alarcón, CEO of Catalyxx, described the funding as a transformative milestone for the company. He stated that the EU's support validates both Catalyxx's technology and its long-term industrial strategy. According to Alarcón, RenewChem will accelerate commercial-scale production while providing industries with renewable chemicals that can be adopted without disrupting existing manufacturing systems. He also emphasized that strengthening Europe's chemical supply security and reducing dependence on imported fossil resources has become increasingly important amid current geopolitical and industrial challenges.
Catalyxx's proprietary conversion technology transforms renewable ethanol into butanol, hexanol, and higher alcohol blends. These products serve as essential intermediates across multiple downstream industries, including coatings, adhesives, resins, lubricants, surfactants, home and personal care products, flavors and fragrances, and sustainable transportation fuels. The company claims these renewable alcohols deliver comparable or enhanced performance relative to petroleum-derived alternatives while significantly lowering carbon emissions and supporting circular economy objectives.
The investment comes at a crucial period for Europe's chemical industry, which faces mounting pressure to decarbonize operations without compromising competitiveness or supply reliability. By enabling large-scale production of renewable drop-in chemicals, RenewChem seeks to provide manufacturers with a practical solution for lowering greenhouse gas emissions while maintaining compatibility with existing production assets. The project is also expected to strengthen Europe's strategic autonomy in critical chemical value chains and accelerate the region's transition toward a more sustainable and resilient chemicals industry.
Impact on Prices of ChemAnalyst-Tracked Chemical Commodities
The immediate impact on commodity prices is expected to be limited, as the commercial plant is still under development. However, over the medium to long term, increased production of bio-based butanol and hexanol could ease supply concerns for renewable grades, potentially moderating price premiums as production scales. Demand for bioethanol may strengthen, providing upward support to ethanol prices, particularly in Europe. Petrochemical-derived alcohols are unlikely to experience significant pricing pressure in the near term, but sustained growth in renewable alternatives could gradually influence market dynamics by increasing competition and encouraging greater price stability for selected oxygenated chemical intermediates.
